Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
2001 3
2002 19
2003 22
2004 58
2005 77
2006 113
2007 139
2008 147
2009 178
2010 166
2011 177
2012 195
2013 204
2014 205
2015 216
2016 212
2017 203
2018 234
2019 221
2020 237
2021 273
2022 301
2023 282
2024 193

Text availability

Article attribute

Article type

Publication date

Search Results

3,526 results

Results by year

Filters applied: . Clear all
Page 1
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial.
Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Hoge EA, et al. JAMA Psychiatry. 2023 Jan 1;80(1):13-21. doi: 10.1001/jamapsychiatry.2022.3679. JAMA Psychiatry. 2023. PMID: 36350591 Free PMC article. Clinical Trial.
Secondary intent-to-treat analyses using imputed data also showed the noninferiority of MBSR compared with escitalopram based on the improvement in CGI-S score. Of patients who started treatment, 10 (8%) dropped out of the escitalopram group and none from the MBSR g …
Secondary intent-to-treat analyses using imputed data also showed the noninferiority of MBSR compared with escitalopram based on the …
Escitalopram.
Landy K, Rosani A, Estevez R. Landy K, et al. 2023 Nov 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Nov 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32491666 Free Books & Documents.
Escitalopram, the (S)-enantiomer of citalopram, is a highly selective serotonin reuptake inhibitor. ...Safe and effective treatment of escitalopram requires an understanding of its potential adverse effects and drug interactions. ...
Escitalopram, the (S)-enantiomer of citalopram, is a highly selective serotonin reuptake inhibitor. ...Safe and effective treatment o …
The clinical pharmacokinetics of escitalopram.
Rao N. Rao N. Clin Pharmacokinet. 2007;46(4):281-90. doi: 10.2165/00003088-200746040-00002. Clin Pharmacokinet. 2007. PMID: 17375980 Review.
The absorption of escitalopram is not affected by food. The elimination half-life of escitalopram is about 27-33 hours and is consistent with once-daily administration. ...However, ritonavir, a potent inhibitor of CYP3A4, does not affect the pharmacokinetics of e …
The absorption of escitalopram is not affected by food. The elimination half-life of escitalopram is about 27-33 hours and is …
Escitalopram.
[No authors listed] [No authors listed] 2024 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000334 Free Books & Documents. Review.
Escitalopram is the active S-isomer of the antidepressant, citalopram. ...If escitalopram is required by the mother, it is not a reason to discontinue breastfeeding. ...
Escitalopram is the active S-isomer of the antidepressant, citalopram. ...If escitalopram is required by the mother, it is not …
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.
Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME. Becker AM, et al. Clin Pharmacol Ther. 2022 Apr;111(4):886-895. doi: 10.1002/cpt.2487. Epub 2021 Nov 22. Clin Pharmacol Ther. 2022. PMID: 34743319 Free PMC article. Clinical Trial.
Pretreatment consisted of 10 mg escitalopram daily for 7 days, followed by 20 mg daily for 7 days, including the day of psilocybin administration, or 14 days of placebo pretreatment before psilocybin administration. ...Escitalopram did not alter HTR2A or SCL6A4 gene …
Pretreatment consisted of 10 mg escitalopram daily for 7 days, followed by 20 mg daily for 7 days, including the day of psilocybin ad …
Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis.
Yin J, Song X, Wang C, Lin X, Miao M. Yin J, et al. BMC Psychiatry. 2023 Nov 24;23(1):876. doi: 10.1186/s12888-023-05382-8. BMC Psychiatry. 2023. PMID: 38001423 Free PMC article.
RESULTS: A total of 30 studies were included in this meta-analysis, among which sixteen trials compared escitalopram with another SSRI and 14 compared escitalopram with a newer AD. ...Escitalopram was also more effective than citalopram in terms of remission …
RESULTS: A total of 30 studies were included in this meta-analysis, among which sixteen trials compared escitalopram with another SSR …
Escitalopram-associated rhabdomyolysis.
Mathisen KK, Hardersen R. Mathisen KK, et al. Tidsskr Nor Laegeforen. 2023 Aug 24;143(12). doi: 10.4045/tidsskr.23.0093. Print 2023 Sep 5. Tidsskr Nor Laegeforen. 2023. PMID: 37668131 Free article. English, Norwegian.
This case history describes a case of rhabdomyolysis resulting from treatment with escitalopram as monotherapy at the recommended dose. This is a rare and little-known side effect of selective serotonin reuptake inhibitors....
This case history describes a case of rhabdomyolysis resulting from treatment with escitalopram as monotherapy at the recommended dos …
Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells.
Chen VC, Hsieh YH, Chen LJ, Hsu TC, Tzang BS. Chen VC, et al. J Cell Mol Med. 2018 Feb;22(2):1167-1178. doi: 10.1111/jcmm.13372. Epub 2017 Nov 3. J Cell Mol Med. 2018. PMID: 29105282 Free PMC article.
However, limited information is revealed about the influence of escitalopram oxalate on GBM. Therefore, an attempt was made herein to explore the effects of escitalopram oxalate on GBM. ...These findings implied that escitalopram oxalate …
However, limited information is revealed about the influence of escitalopram oxalate on GBM. Therefore, an attempt was made he …
Escitalopram.
Burke WJ. Burke WJ. Expert Opin Investig Drugs. 2002 Oct;11(10):1477-86. doi: 10.1517/13543784.11.10.1477. Expert Opin Investig Drugs. 2002. PMID: 12387707 Review.
Escitalopram oxalate (S-citalopram, Lexapro), a selective serotonin re-uptake inhibitor antidepressant which is the S-enantiomer of citalopram, is in clinical development worldwide for the treatment of depression and anxiety disorders. ...Only nausea occurred in &gt …
Escitalopram oxalate (S-citalopram, Lexapro), a selective serotonin re-uptake inhibitor antidepressant which is the S-enantiom …
A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.
Strawn JR, Moldauer L, Hahn RD, Wise A, Bertzos K, Eisenberg B, Greenberg E, Liu C, Gopalkrishnan M, McVoy M, Knutson JA. Strawn JR, et al. J Child Adolesc Psychopharmacol. 2023 Apr;33(3):91-100. doi: 10.1089/cap.2023.0004. J Child Adolesc Psychopharmacol. 2023. PMID: 37074330 Clinical Trial.
Vital signs, weight, laboratory, and electrocardiographic results were consistent with previous pediatric studies of escitalopram. Conclusions: Escitalopram reduced anxiety symptoms and was well tolerated in pediatric patients with GAD. These findings confirm earlie …
Vital signs, weight, laboratory, and electrocardiographic results were consistent with previous pediatric studies of escitalopram. Co …
3,526 results